| 139.57 20.37 (17.09%) | 05-01 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 165.73  |
1-year : | 193.58 |
| Resists | First : | 141.89 |
Second : | 165.73 |
| Pivot price | 111.23 |
|||
| Supports | First : | 109.33 |
Second : | 89.19 |
| MAs | MA(5) : | 119.33 |
MA(20) : | 109.19 |
| MA(100) : | 128.33  |
MA(250) : | 120.06 |
|
| MACD | MACD : | 5.3 |
Signal : | 2.6 |
| %K %D | K(14,3) : | 87.7 |
D(3) : | 86.4 |
| RSI | RSI(14): 75.1 |
|||
| 52-week | High : | 193.07 | Low : | 77.2 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ NUTX ] has closed Bollinger Bands are 22% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 142.07 - 142.6 | 142.6 - 143.03 |
| Low: | 118.28 - 118.86 | 118.86 - 119.32 |
| Close: | 138.58 - 139.6 | 139.6 - 140.42 |
Sat, 02 May 2026
Nutex Health, Inc. (NASDAQ:NUTX) Q1 2026 Earnings Call Transcript - Insider Monkey
Thu, 30 Apr 2026
Nutex Health (NASDAQ:NUTX) Issues Quarterly Earnings Results, Beats Expectations By $2.53 EPS - MarketBeat
Thu, 30 Apr 2026
Nutex Health (NASDAQ:NUTX) Faces Mixed Q1 Results as Revenue Miss Offsets Strong EPS Beat - ChartMill
Thu, 30 Apr 2026
NUTX: Net income more than doubled and cash flow surged, supporting new hospital expansion in 2026 - TradingView
Thu, 30 Apr 2026
Earnings Flash (NUTX) Nutex Health Inc. Reports Q1 Revenue $216.5M, vs. FactSet Est of $227.8M - marketscreener.com
Thu, 30 Apr 2026
Nutex Health Inc. (NUTX) Stock Rises on Q1 2026 Earnings - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 7 (M) |
| Shares Float | 4 (M) |
| Held by Insiders | 28.6 (%) |
| Held by Institutions | 40.1 (%) |
| Shares Short | 994 (K) |
| Shares Short P.Month | 928 (K) |
| EPS | 10.47 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 46.49 |
| Profit Margin | 8 % |
| Operating Margin | 97.5 % |
| Return on Assets (ttm) | 31.1 % |
| Return on Equity (ttm) | 58.9 % |
| Qtrly Rev. Growth | -41.1 % |
| Gross Profit (p.s.) | 67.61 |
| Sales Per Share | 125.57 |
| EBITDA (p.s.) | 59.27 |
| Qtrly Earnings Growth | -86.2 % |
| Operating Cash Flow | 248 (M) |
| Levered Free Cash Flow | 153 (M) |
| PE Ratio | 13.33 |
| PEG Ratio | 0 |
| Price to Book value | 3 |
| Price to Sales | 1.11 |
| Price to Cash Flow | 3.92 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|